+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Medical Crowdfunding Market by Disease Category (Cardiology, Mental Health, Neurology), Platform Type (Charity Specific, General Purpose, Healthcare Specific), Campaign Type, Donation Source, Funding Goal Range, Recipient Age Group - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6134492
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Unveiling The Growing Force Of Medical Crowdfunding As A Sustainable Means To Empower Patients Bridge Funding Gaps And Amplify Community Support

Medical crowdfunding has emerged as a powerful mechanism to bridge financial gaps faced by patients with complex or costly conditions. By harnessing digital networks and social media amplification, individuals and families can share authentic narratives that resonate deeply with diverse donor communities. Over the past decade, crowdfunding platforms have transcended their initial charitable roots to become sophisticated ecosystems where campaigners engage supporters through real-time updates, multimedia storytelling, and transparent fund allocation disclosures. Consequently, patients navigating cardiology, oncology, rare diseases, or rehabilitation journeys no longer rely solely on traditional insurance or grant systems. Instead, they can connect with global audiences who empathize with personal health struggles and desire tangible opportunities to make a difference.

Furthermore, technological advancements and evolving philanthropic mindsets have cultivated an environment in which digital generosity flourishes. The proliferation of user-friendly platforms tailored to healthcare needs has lowered barriers for campaign creation, while integrated payment solutions expedite donation flows. Simultaneously, the rise of community-driven initiatives and peer-to-peer fundraising has reinforced the social dimension of giving, fostering a sense of shared purpose among donors. As patients become more proactive in advocating for their own care, medical crowdfunding operates at the intersection of healthcare innovation and communal solidarity, redefining how financial support for medical interventions is mobilized.

Identifying The Fundamental Shifts In Medical Crowdfunding Ecosystems That Are Redefining Funding Pathways And Donor Engagement Globally

The medical crowdfunding landscape is undergoing fundamental transformations driven by technological innovation, evolving donor expectations, and shifts in regulatory scrutiny. Artificial intelligence and machine learning algorithms are enhancing campaign discoverability and personalizing donor outreach, while mobile wallet integration and seamless payment gateways are accelerating contribution flows. As platforms incorporate data-driven insights, they can optimize campaign recommendations and predict funding outcomes more effectively, leading to heightened competition among platform providers seeking to differentiate their services.

In parallel, donor engagement models are evolving beyond one-time donations toward sustained relationships. Recurring contributions, impact tracking, and interactive storytelling have become pivotal in retaining supporter interest. Gamification elements and social sharing capabilities are fostering micro-giving communities that rally around specific patient stories or disease categories. This social activation not only amplifies fundraising potential but also strengthens the emotional bonds between donors and beneficiaries.

At the same time, expectations for transparency and compliance are intensifying. Platforms are investing in robust identity verification processes, outcome reporting, and fraud prevention mechanisms to uphold trust and comply with tightening regulations. As a result, medical crowdfunding providers are redefining governance frameworks, forging partnerships with nonprofit organizations and clinical institutions to ensure the integrity of campaigns and reassure donors about the ethical deployment of funds.

Analyzing The Cumulative Impact Of The United States Tariffs In 2025 On Medical Crowdfunding Operations Regulatory Compliance And Platform Sustainability

The introduction of new tariffs by the United States in 2025 has presented a series of operational and compliance challenges for medical crowdfunding platforms. Payment processing fees have risen as cross-border transaction costs have become subject to additional levies, prompting platforms to reassess their pricing models. Consequently, those reliant on international donor bases have had to weigh the trade-off between maintaining global reach and absorbing incremental expenses.

Moreover, platforms have faced heightened scrutiny around regulatory reporting and documentation to demonstrate adherence to tariff exemptions for charitable causes. This has necessitated the development of more sophisticated compliance teams and the integration of automated systems capable of validating donor locations and transaction purposes. In turn, platform providers are reevaluating their technology stacks and forging alliances with local payment processors to circumvent prohibitively high tariff charges.

In response to these pressures, a number of leading platforms are piloting regionally focused initiatives that leverage localized partnerships to minimize cross border fees. By collaborating with domestic financial institutions and nonprofit organizations, they aim to preserve donor confidence while mitigating cost escalations. These strategic adaptations underscore the resilience of the medical crowdfunding market in navigating evolving regulatory environments without compromising platform sustainability or campaign outcomes.

Unlocking Crucial Segmentation Insights To Understand How Disease Categories Campaign Types And Funding Structures Shape Crowdfunding Dynamics For Healthcare

Understanding the nuances of campaign performance requires a deep dive into disease category segmentation, which ranges from cardiology and mental health to neurology, oncology, orthopedics, pediatrics, rare diseases, rehabilitation, and transplants. Within cardiology, subsegments such as arrhythmia, coronary artery disease, and heart failure each display unique donor engagement patterns driven by prevalence, treatment urgency, and public awareness. Oncology campaigns, especially those focused on breast cancer, leukemia, lung cancer, and prostate cancer, consistently evoke strong emotional responses and benefit from dedicated advocacy communities. By contrast, rare disease campaigns including cystic fibrosis, muscular dystrophy, and sickle cell disease rely heavily on targeted outreach to specialized philanthropic groups.

Platform type segmentation reveals distinct strategic approaches among charity-specific platforms like JustGiving and YouCaring, which excel at facilitating tax-benefit eligibility, versus general purpose platforms such as GoFundMe, Indiegogo, and Kickstarter that offer broad audience reach. Healthcare-specific providers including MedStartr and Plumfund differentiate themselves through integrated medical compliance tools, while hybrid models leverage the strengths of each to offer flexible fundraising frameworks.

Campaign type, whether charity, individual, or research-oriented, shapes donor motivations and expectations. Research campaigns, particularly those funding clinical trials and medical technology development, appeal to donors interested in long-term impact and scientific advancement. Donations sourced from corporate donors and foundations tend to support high-value initiatives, whereas individual donors, spanning high net worth contributors to small donors, sustain grassroots efforts. Campaigns targeting funding goals below $10,000 often achieve rapid traction through peer networks, while those aiming for $10,000 to $50,000 strike a balance between ambition and attainability. Goals exceeding $50,000 typically necessitate multi-channel marketing strategies. Finally, recipient age groups, from adults to pediatrics-including adolescents, childhood, and neonatal care-and seniors, influence narrative tone and campaign structuring to resonate with age-aligned donor cohorts.

Examining Regional Dynamics Across Americas Europe Middle East Africa And Asia Pacific To Reveal Divergent Trends In Crowdfunding Adoption And Donor Behavior

Regional dynamics play a pivotal role in shaping medical crowdfunding trajectories, each geography presenting a unique blend of regulatory frameworks, cultural norms, and digital adoption rates. In the Americas, established platforms benefit from widespread internet penetration and strong philanthropic traditions, contributing to rapid campaign growth and diversified donor pools. By contrast, Europe, the Middle East & Africa showcase emerging opportunities where donor regulations and fundraising guidelines vary significantly, requiring platforms to navigate complex legal environments and build trust through local certification partnerships.

The Asia-Pacific region, characterized by high mobile connectivity and rising middle-class populations, is witnessing a surge in platform innovation aimed at mobile-first user experiences. Localized payment solutions and vernacular content are critical to engaging donors across diverse linguistic and cultural landscapes. Transitional regulations across Asia are driving platforms to adopt modular compliance frameworks that can be adapted to each country’s unique requirements, from charitable registration protocols to data privacy mandates.

Across all regions, collaboration with healthcare institutions, local nonprofits, and community influencers has emerged as a cornerstone of successful campaigns. By tailoring outreach strategies to regional donor behaviors-whether leveraging community fundraising events in the Americas or mobile-based microgiving in Asia-Pacific-platforms can optimize engagement and foster sustainable support networks.

Highlighting Key Industry Players In The Medical Crowdfunding Market And Assessing Their Strategic Partnerships Platform Innovations And Growth Initiatives

Several leading companies have established themselves as frontrunners in medical crowdfunding through strategic investments in technology, partnerships, and service innovation. GoFundMe, a pioneer in the general purpose space, continues to enhance its platform with AI-based campaign recommendations and real-time progress tracking. JustGiving and YouCaring, operating under charity-specific models, emphasize compliance with tax-deductible donation systems and have forged alliances with global nonprofit entities to broaden their user base.

Emerging players such as MedStartr and Plumfund have carved out niches by integrating medical expertise into platform workflows, offering campaign verification services and end-to-end fund disbursement solutions that meet stringent healthcare regulations. Indiegogo and Kickstarter, while traditionally focused on creative projects, have experimented with healthcare categories to tap into social impact initiatives and research funding campaigns. Hybrid providers are now exploring white-label solutions for hospital networks and research institutions, enabling custom branded fundraising portals that align with organizational objectives.

Collectively, these platforms are investing in user experience enhancements such as mobile app interfaces, donor retention analytics, and peer-to-peer fundraising toolkits. Strategic acquisitions and partnership agreements with payment processors, telemedicine providers, and patient advocacy groups underscore a broader trend toward ecosystem integration, designed to streamline campaign management and elevate donor confidence.

Formulating Strategic Recommendations To Guide Industry Leaders In Optimizing Platform Capabilities Enhancing Donor Engagement And Ensuring Regulatory Readiness

To navigate the rapidly evolving medical crowdfunding landscape, industry leaders should prioritize the development of advanced data analytics capabilities that enable personalized donor engagement. By leveraging machine learning algorithms to identify donor preferences and anticipate giving behavior, platforms can tailor campaign recommendations and communication strategies, boosting conversion rates and fostering long-term supporter relationships.

In addition, investing in compliance automation tools will streamline regulatory adherence and mitigate risk. Integrating identity verification, outcome reporting, and fraud detection systems into core platform functionalities can reinforce trust among donors and healthcare partners. Collaborative alliances with nonprofit organizations, academic research institutions, and hospital networks will further validate campaign legitimacy and create pathways for joint fundraising initiatives.

Finally, enhancing accessibility through multilingual mobile-first design and modular payment integration will unlock new donor segments across emerging regions. Incorporating community features, such as peer-to-peer fundraising challenges and donor recognition programs, can galvanize supporter networks and maintain momentum. By embracing these actionable strategies, platform providers and stakeholders will position themselves for sustained growth, deeper patient impact, and robust resilience in a dynamic regulatory environment.

Demystifying The Research Methodology Underpinning Medical Crowdfunding Analysis Including Data Collection Framework And Analytical Techniques

The research methodology employed to analyze the medical crowdfunding ecosystem combined qualitative and quantitative approaches to ensure comprehensive insight validation. Primary research included in-depth interviews with platform executives, campaign organizers, donor focus groups, and regulatory experts, capturing firsthand perspectives on emerging trends and operational challenges. Supplementing these insights, an extensive review of publicly available data sources, academic publications, and nonprofit disclosures provided context on campaign outcomes, donor demographics, and regional regulatory frameworks.

A structured analytical framework guided the segmentation of disease categories, platform types, campaign models, donation sources, funding goal ranges, and recipient age cohorts. Each segment underwent a comparative assessment to identify performance drivers and risk factors. Financial transaction data and platform-level metrics were triangulated with qualitative feedback to highlight best practices and innovation opportunities.

Finally, iterative validation sessions with subject matter experts ensured the accuracy and relevance of findings. These collaborative reviews refined strategic recommendations, aligned insights with stakeholder priorities, and confirmed the applicability of proposed frameworks across diverse regulatory environments. This rigorous methodology underpins the credibility and actionability of the research conclusions.

Drawing Comprehensive Conclusions On The Future Trajectory Of Medical Crowdfunding Emphasizing Sustainability Scalability And Stakeholder Collaboration

In conclusion, medical crowdfunding has solidified its role as an indispensable channel for mobilizing healthcare funding in an era of rising treatment costs and evolving donor dynamics. Platforms that excel will be those capable of integrating advanced analytics, ensuring stringent compliance, and nurturing authentic relationships with patient communities. Disease category and regional segmentation analyses underscore the importance of tailored outreach strategies, while platform differentiation reveals opportunities for niche specialization and ecosystem collaboration.

Regulatory developments, such as the 2025 tariff adjustments, highlight the need for agile operational models that can adapt to shifting policy landscapes without impeding campaign momentum. Equally, the expansion of campaign types-from individual assistance to research-focused initiatives-reinforces the necessity of robust verification and outcome reporting standards.

Looking ahead, sustained success in medical crowdfunding will hinge on the ability of platform providers and stakeholders to foster transparent, scalable, and community-centered fundraising ecosystems. By embracing collaborative partnerships with healthcare institutions, leveraging emerging technologies, and maintaining a donor-centric ethos, the industry can continue to empower patients and catalyze meaningful change in global health outcomes.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Disease Category
    • Cardiology
      • Arrhythmia
      • Coronary Artery Disease
      • Heart Failure
    • Mental Health
    • Neurology
    • Oncology
      • Breast Cancer
      • Leukemia
      • Lung Cancer
      • Prostate Cancer
    • Orthopedics
    • Pediatrics
    • Rare Diseases
      • Cystic Fibrosis
      • Muscular Dystrophy
      • Sickle Cell Disease
    • Rehabilitation
    • Transplants
  • Platform Type
    • Charity Specific
      • JustGiving
      • YouCaring
    • General Purpose
      • GoFundMe
      • Indiegogo
      • Kickstarter
    • Healthcare Specific
      • MedStartr
      • Plumfund
    • Hybrid
  • Campaign Type
    • Charity
    • Individual
    • Research
      • Clinical Trials
      • Medical Technologies
  • Donation Source
    • Corporate Donors
    • Foundations
    • Individual Donors
      • High Net Worth
      • Mid Tier
      • Small Donors
  • Funding Goal Range
    • 10k to 50k
    • Above 50k
    • Below 10k
  • Recipient Age Group
    • Adults
    • Pediatrics
      • Adolescents
      • Childhood
      • Neonatal
    • Seniors
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • GoFundMe, Inc.
  • JustGiving Limited
  • Fundly, Inc.
  • FundRazr, Inc.
  • GiveButter, Inc.
  • Mightycause, Inc.
  • Plumfund, Inc.
  • Generosity.com, Inc.
  • Watsi, Inc.
  • GiveSendGo, LLC

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rise of social media platform integration to amplify medical crowdfunding campaigns for rare diseases
5.2. Increasing use of blockchain technology to ensure transparency in patient funding journeys
5.3. Growth of medical crowdfunding platforms specializing in mental health treatment funding
5.4. Collaboration between healthcare providers and crowdfunding sites to expedite critical treatment financing
5.5. Emergence of AI-driven personalized campaign optimization tools boosting donor engagement
5.6. Expansion of cross-border medical crowdfunding for patients seeking treatment abroad
5.7. Adoption of subscription-based donor models to provide continuous support for chronic illness patients
5.8. Development of regulatory frameworks addressing fraud prevention and donor protection in medical crowdfunding
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Medical Crowdfunding Market, by Disease Category
8.1. Introduction
8.2. Cardiology
8.2.1. Arrhythmia
8.2.2. Coronary Artery Disease
8.2.3. Heart Failure
8.3. Mental Health
8.4. Neurology
8.5. Oncology
8.5.1. Breast Cancer
8.5.2. Leukemia
8.5.3. Lung Cancer
8.5.4. Prostate Cancer
8.6. Orthopedics
8.7. Pediatrics
8.8. Rare Diseases
8.8.1. Cystic Fibrosis
8.8.2. Muscular Dystrophy
8.8.3. Sickle Cell Disease
8.9. Rehabilitation
8.10. Transplants
9. Medical Crowdfunding Market, by Platform Type
9.1. Introduction
9.2. Charity Specific
9.2.1. JustGiving
9.2.2. YouCaring
9.3. General Purpose
9.3.1. GoFundMe
9.3.2. Indiegogo
9.3.3. Kickstarter
9.4. Healthcare Specific
9.4.1. MedStartr
9.4.2. Plumfund
9.5. Hybrid
10. Medical Crowdfunding Market, by Campaign Type
10.1. Introduction
10.2. Charity
10.3. Individual
10.4. Research
10.4.1. Clinical Trials
10.4.2. Medical Technologies
11. Medical Crowdfunding Market, by Donation Source
11.1. Introduction
11.2. Corporate Donors
11.3. Foundations
11.4. Individual Donors
11.4.1. High Net Worth
11.4.2. Mid Tier
11.4.3. Small Donors
12. Medical Crowdfunding Market, by Funding Goal Range
12.1. Introduction
12.2. 10k to 50k
12.3. Above 50k
12.4. Below 10k
13. Medical Crowdfunding Market, by Recipient Age Group
13.1. Introduction
13.2. Adults
13.3. Pediatrics
13.3.1. Adolescents
13.3.2. Childhood
13.3.3. Neonatal
13.4. Seniors
14. Americas Medical Crowdfunding Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Medical Crowdfunding Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Medical Crowdfunding Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. GoFundMe, Inc.
17.3.2. JustGiving Limited
17.3.3. Fundly, Inc.
17.3.4. FundRazr, Inc.
17.3.5. GiveButter, Inc.
17.3.6. Mightycause, Inc.
17.3.7. Plumfund, Inc.
17.3.8. Generosity.com, Inc.
17.3.9. Watsi, Inc.
17.3.10. GiveSendGo, LLC
18. ResearchAI19. ResearchStatistics20. ResearchContacts21. ResearchArticles22. Appendix
List of Figures
FIGURE 1. MEDICAL CROWDFUNDING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY DISEASE CATEGORY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY DISEASE CATEGORY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY PLATFORM TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY PLATFORM TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY CAMPAIGN TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY CAMPAIGN TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY DONATION SOURCE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY DONATION SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY FUNDING GOAL RANGE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY FUNDING GOAL RANGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY RECIPIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY RECIPIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MEDICAL CROWDFUNDING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MEDICAL CROWDFUNDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC MEDICAL CROWDFUNDING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC MEDICAL CROWDFUNDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. MEDICAL CROWDFUNDING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. MEDICAL CROWDFUNDING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. MEDICAL CROWDFUNDING MARKET: RESEARCHAI
FIGURE 28. MEDICAL CROWDFUNDING MARKET: RESEARCHSTATISTICS
FIGURE 29. MEDICAL CROWDFUNDING MARKET: RESEARCHCONTACTS
FIGURE 30. MEDICAL CROWDFUNDING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MEDICAL CROWDFUNDING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY ARRHYTHMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY ARRHYTHMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY HEART FAILURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY MENTAL HEALTH, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY MENTAL HEALTH, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY RARE DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY MUSCULAR DYSTROPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY MUSCULAR DYSTROPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY SICKLE CELL DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY SICKLE CELL DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY REHABILITATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY TRANSPLANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY TRANSPLANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY PLATFORM TYPE, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY PLATFORM TYPE, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY CHARITY SPECIFIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY CHARITY SPECIFIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY JUSTGIVING, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY JUSTGIVING, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY YOUCARING, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY YOUCARING, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY CHARITY SPECIFIC, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY CHARITY SPECIFIC, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY GENERAL PURPOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY GENERAL PURPOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY GOFUNDME, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY GOFUNDME, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY INDIEGOGO, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY INDIEGOGO, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY KICKSTARTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY KICKSTARTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY GENERAL PURPOSE, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY GENERAL PURPOSE, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY HEALTHCARE SPECIFIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY HEALTHCARE SPECIFIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY MEDSTARTR, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY MEDSTARTR, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY PLUMFUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY PLUMFUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY HEALTHCARE SPECIFIC, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY HEALTHCARE SPECIFIC, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY HYBRID, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY HYBRID, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY CAMPAIGN TYPE, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY CAMPAIGN TYPE, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY CHARITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY CHARITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY INDIVIDUAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY INDIVIDUAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY MEDICAL TECHNOLOGIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY MEDICAL TECHNOLOGIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY DONATION SOURCE, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY DONATION SOURCE, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY CORPORATE DONORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY CORPORATE DONORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY FOUNDATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY FOUNDATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY INDIVIDUAL DONORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY INDIVIDUAL DONORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY HIGH NET WORTH, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY HIGH NET WORTH, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY MID TIER, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY MID TIER, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY SMALL DONORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY SMALL DONORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY INDIVIDUAL DONORS, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY INDIVIDUAL DONORS, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY FUNDING GOAL RANGE, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY FUNDING GOAL RANGE, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY 10K TO 50K, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY 10K TO 50K, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY ABOVE 50K, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY ABOVE 50K, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY BELOW 10K, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY BELOW 10K, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY RECIPIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY ADULTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY ADOLESCENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY ADOLESCENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY CHILDHOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY CHILDHOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY NEONATAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY NEONATAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY SENIORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL MEDICAL CROWDFUNDING MARKET SIZE, BY SENIORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY PLATFORM TYPE, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY PLATFORM TYPE, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY CHARITY SPECIFIC, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY CHARITY SPECIFIC, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY GENERAL PURPOSE, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY GENERAL PURPOSE, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY HEALTHCARE SPECIFIC, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY HEALTHCARE SPECIFIC, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY CAMPAIGN TYPE, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY CAMPAIGN TYPE, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY DONATION SOURCE, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY DONATION SOURCE, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY INDIVIDUAL DONORS, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY INDIVIDUAL DONORS, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY FUNDING GOAL RANGE, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY FUNDING GOAL RANGE, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY RECIPIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS MEDICAL CROWDFUNDING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY PLATFORM TYPE, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY PLATFORM TYPE, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY CHARITY SPECIFIC, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY CHARITY SPECIFIC, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY GENERAL PURPOSE, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY GENERAL PURPOSE, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY HEALTHCARE SPECIFIC, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY HEALTHCARE SPECIFIC, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY CAMPAIGN TYPE, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY CAMPAIGN TYPE, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY DONATION SOURCE, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY DONATION SOURCE, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY INDIVIDUAL DONORS, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY INDIVIDUAL DONORS, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY FUNDING GOAL RANGE, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY FUNDING GOAL RANGE, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY RECIPIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES MEDICAL CROWDFUNDING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 203. CANADA MEDICAL CROWDFUNDING MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
TABLE 204. CANADA MEDICAL CROWDFUNDING MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
TABLE 205. CANADA MEDICAL CROWDFUNDING MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 206. CANADA MEDICAL CROWDFUNDING MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 207. CANADA MEDICAL CROWDFUNDING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 208. CANADA MEDICAL CROWDFUNDING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 209. CANADA MEDICAL CROWDFUNDING MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 210. CANADA MEDICAL CROWDFUNDING MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 211. CANADA MEDICAL CROWDFUNDING MARKET SIZE, BY PLATFORM TYPE, 2018-2024 (USD MILLION)
TABLE 212. CANADA MEDICAL CROWDFUNDING MARKET SIZE, BY PLATFORM TYPE, 2025-2030 (USD MILLION)
TABLE 213. CANADA MEDICAL CROWDFUNDING MARKET SIZE, BY CHARITY SPECIFIC, 2018-2024 (USD MILLION)
TABLE 214. CANADA MEDICAL CROWDFUNDING MARKET SIZE, BY CHARITY SPECIFIC, 2025-2030 (USD MILLION)
TABLE 215. CANADA MEDICAL CROWDFUNDING MARKET SIZE, BY GENERAL PURPOSE, 2018-2024 (USD MILLION)
TABLE 216. CANADA MEDICAL CROWDFUNDING MARKET SIZE, BY GENERAL PURPOSE, 2025-2030 (USD MILLION)
TABLE 217. CANADA MEDICAL CROWDFUNDING MARKET SIZE, BY HEALTHCARE SPECIFIC, 2018-2024 (USD MILLION)
TABLE 218. CANADA MEDICAL CROWDFUNDING MARKET SIZE, BY HEALTHCARE SPECIFIC, 2025-2030 (USD MILLION)
TABLE 219. CANADA MEDICAL CROWDFUNDING MARKET SIZE, BY CAMPAIGN TYPE, 2018-2024 (USD MILLION)
TABLE 220. CANADA MEDICAL CROWDFUNDING MARKET SIZE, BY CAMPAIGN TYPE, 2025-2030 (USD MILLION)
TABLE 221. CANADA MEDICAL CROWDFUNDING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 222. CANADA MEDICAL CROWDFUNDING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 223. CANADA MEDICAL CROWDFUNDING MARKET SIZE, BY DONATION SOURCE, 2018-2024 (USD MILLION)
TABLE 224. CANADA MEDICAL CROWDFUNDING MARKET SIZE, BY DONATION SOURCE, 2025-2030 (USD MILLION)
TABLE 225. CANADA MEDICAL CROWDFUNDING MARKET SIZE, BY INDIVIDUAL DONORS, 2018-2024 (USD MILLION)
TABLE 226. CANADA MEDICAL CROWDFUNDING MARKET SIZE, BY INDIVIDUAL DONORS, 2025-2030 (USD MILLION)
TABLE 227. CANADA MEDICAL CROWDFUNDING MARKET SIZE, BY FUNDING GOAL RANGE, 2018-2024 (USD MILLION)
TABLE 228. CANADA MEDICAL CROWDFUNDING MARKET SIZE, BY FUNDING GOAL RANGE, 2025-2030 (USD MILLION)
TABLE 229. CANADA MEDICAL CROWDFUNDING MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 230. CANADA MEDICAL CROWDFUNDING MARKET SIZE, BY RECIPIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 231. CANADA MEDICAL CROWDFUNDING MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 232. CANADA MEDICAL CROWDFUNDING MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 233. MEXICO MEDICAL CROWDFUNDING MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
TABLE 234. MEXICO MEDICAL CROWDFUNDING MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
TABLE 235. MEXICO MEDICAL CROWDFUNDING MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 236. MEXICO MEDICAL CROWDFUNDING MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 237. MEXICO MEDICAL CROWDFUNDING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 238. MEXICO MEDICAL CROWDFUNDING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 239. MEXICO MEDICAL CROWDFUNDING MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 240. MEXICO MEDICAL CROWDFUNDING MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 241. MEXICO MEDICAL CROWDFUNDING MARKET SIZE, BY PLATFORM TYPE, 2018-2024 (USD MILLION)
TABLE 242. MEXICO MEDICAL CROWDFUNDING MARKET SIZE, BY PLATFORM TYPE, 2025-2030 (USD MILLION)
TABLE 243. MEXICO MEDICAL CROWDFUNDING MARKET SIZE, BY CHARITY SPECIFIC, 2018-2024 (USD MILLION)
TABLE 244. MEXICO MEDICAL CROWDFUNDING MARKET SIZE, BY CHARITY SPECIFIC, 2025-2030 (USD MILLION)
TABLE 245. MEXICO MEDICAL CROWDFUNDING MARKET SIZE, BY GENERAL PURPOSE, 2018-2024 (USD MILLION)
TABLE 246. MEXICO MEDICAL CROWDFUNDING MARKET SIZE, BY GENERAL PURPOSE, 2025-2030 (USD MILLION)
TABLE 247. MEXICO MEDICAL CROWDFUNDING MARKET SIZE, BY HEALTHCARE SPECIFIC, 2018-2024 (USD MILLION)
TABLE 248. MEXICO MEDICAL CROWDFUNDING MARKET SIZE, BY HEALTHCARE SPECIFIC, 2025-2030 (USD MILLION)
TABLE 249. MEXICO MEDICAL CROWDFUNDING MARKET SIZE, BY CAMPAIGN TYPE, 2018-2024 (USD MILLION)
TABLE 250. MEXICO MEDICAL CROWDFUNDING MARKET SIZE, BY CAMPAIGN TYPE, 2025-2030 (USD MILLION)
TABLE 251. MEXICO MEDICAL CROWDFUNDING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 252. MEXICO MEDICAL CROWDFUNDING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 253. MEXICO MEDICAL CROWDFUNDING MARKET SIZE, BY DONATION SOURCE, 2018-2024 (USD MILLION)
TABLE 254. MEXICO MEDICAL CROWDFUNDING MARKET SIZE, BY DONATION SOURCE, 2025-2030 (USD MILLION)
TABLE 255. MEXICO MEDICAL CROWDFUNDING MARKET SIZE, BY INDIVIDUAL DONORS, 2018-2024 (USD MILLION)
TABLE 256. MEXICO MEDICAL CROWDFUNDING MARKET SIZE, BY INDIVIDUAL DONORS, 2025-2030 (USD MILLION)
TABLE 257. MEXICO MEDICAL CROWDFUNDING MARKET SIZE, BY FUNDING GOAL RANGE, 2018-2024 (USD MILLION)
TABLE 258. MEXICO MEDICAL CROWDFUNDING MARKET SIZE, BY FUNDING GOAL RANGE, 2025-2030 (USD MILLION)
TABLE 259. MEXICO MEDICAL CROWDFUNDING MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 260. MEXICO MEDICAL CROWDFUNDING MARKET SIZE, BY RECIPIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 261. MEXICO MEDICAL CROWDFUNDING MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 262. MEXICO MEDICAL CROWDFUNDING MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL MEDICAL CROWDFUNDING MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL MEDICAL CROWDFUNDING MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL MEDICAL CROWDFUNDING MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL MEDICAL CROWDFUNDING MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL MEDICAL CROWDFUNDING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL MEDICAL CROWDFUNDING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL MEDICAL CROWDFUNDING MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL MEDICAL CROWDFUNDING MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL MEDICAL CROWDFUNDING MARKET SIZE, BY PLATFORM TYPE, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL MEDICAL CROWDFUNDING MARKET SIZE, BY PLATFORM TYPE, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL MEDICAL CROWDFUNDING MARKET SIZE, BY CHARITY SPECIFIC, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL MEDICAL CROWDFUNDING MARKET SIZE, BY CHARITY SPECIFIC, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL MEDICAL CROWDFUNDING MARKET SIZE, BY GENERAL PURPOSE, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL MEDICAL CROWDFUNDING MARKET SIZE, BY GENERAL PURPOSE, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL MEDICAL CROWDFUNDING MARKET SIZE, BY HEALTHCARE SPECIFIC, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL MEDICAL CROWDFUNDING MARKET SIZE, BY HEALTHCARE SPECIFIC, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL MEDICAL CROWDFUNDING MARKET SIZE, BY CAMPAIGN TYPE, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL MEDICAL CROWDFUNDING MARKET SIZE, BY CAMPAIGN TYPE, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL MEDICAL CROWDFUNDING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL MEDICAL CROWDFUNDING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL MEDICAL CROWDFUNDING MARKET SIZE, BY DONATION SOURCE, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL MEDICAL CROWDFUNDING MARKET SIZE, BY DONATION SOURCE, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL MEDICAL CROWDFUNDING MARKET SIZE, BY INDIVIDUAL DONORS, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL MEDICAL CROWDFUNDING MARKET SIZE, BY INDIVIDUAL DONORS, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL MEDICAL CROWDFUNDING MARKET SIZE, BY FUNDING GOAL RANGE, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL MEDICAL CROWDFUNDING MARKET SIZE, BY FUNDING GOAL RANGE, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL MEDICAL CROWDFUNDING MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL MEDICAL CROWDFUNDING MARKET SIZE, BY RECIPIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL MEDICAL CROWDFUNDING MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL MEDICAL CROWDFUNDING MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA MEDICAL CROWDFUNDING MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA MEDICAL CROWDFUNDING MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA MEDICAL CROWDFUNDING MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA MEDICAL CROWDFUNDING MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA MEDICAL CROWDFUNDING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA MEDICAL CROWDFUNDING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA MEDICAL CROWDFUNDING MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA MEDICAL CROWDFUNDING MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA MEDICAL CROWDFUNDING MARKET SIZE, BY PLATFORM TYPE, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA MEDICAL CROWDFUNDING MARKET SIZE, BY PLATFORM TYPE, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA MEDICAL CROWDFUNDING MARKET SIZE, BY CHARITY SPECIFIC, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA MEDICAL CROWDFUNDING MARKET SIZE, BY CHARITY SPECIFIC, 2025-2030 (USD MILLION)
TABLE 305. ARGENTINA MEDICAL CROWDFUNDING MARKET SIZE, BY GENERAL PURPOSE, 2018-2024 (USD MILLION)
TABLE 306. ARGENTINA MEDICAL CROWDFUNDING MARKET SIZE, BY GENERAL PURPOSE, 2025-2030 (USD MILLION)
TABLE 307. ARGENTINA MEDICAL CROWDFUNDING MARKET SIZE, BY HEALTHCARE SPECIFIC, 2018-2024 (USD MILLION)
TABLE 308. ARGENTINA MEDICAL CROWDFUNDING MARKET SIZE, BY HEALTHCARE SPECIFIC, 2025-2030 (USD MILLION)
TABLE 309. ARGENTINA MEDICAL CROWDFUNDING MARKET SIZE, BY CAMPAIGN TYPE, 2018-2024 (USD MILLION)
TABLE 310. ARGENTINA MEDICAL CROWDFUNDING MARKET SIZE, BY CAMPAIGN TYPE, 2025-2030 (USD MILLION)
TABLE 311. ARGENTINA MEDICAL CROWDFUNDING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 312. ARGENTINA MEDICAL CROWDFUNDING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 313. ARGENTINA MEDICAL CROWDFUNDING MARKET SIZE, BY DONATION SOURCE, 2018-2024 (USD MILLION)
TABLE 314. ARGENTINA MEDICAL CROWDFUNDING MARKET SIZE, BY DONATION SOURCE, 2025-2030 (USD MILLION)
TABLE 315. ARGENTINA MEDICAL CROWDFUNDING MARKET SIZE, BY INDIVIDUAL DONORS, 2018-2024 (USD MILLION)
TABLE 316. ARGENTINA MEDICAL CROWDFUNDING MARKET SIZE, BY INDIVIDUAL DONORS, 2025-2030 (USD MILLION)
TABLE 317. ARGENTINA MEDICAL CROWDFUNDING MARKET SIZE, BY FUNDING GOAL RANGE, 2018-2024 (USD MILLION)
TABLE 318. ARGENTINA MEDICAL CROWDFUNDING MARKET SIZE, BY FUNDING GOAL RANGE, 2025-2030 (USD MILLION)
TABLE 319. ARGENTINA MEDICAL CROWDFUNDING MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 320. ARGENTINA MEDICAL CROWDFUNDING MARKET SIZE, BY RECIPIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 321. ARGENTINA MEDICAL CROWDFUNDING MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 322. ARGENTINA MEDICAL CROWDFUNDING MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 323. EUROPE, MIDDLE EAST & AFRICA MEDICAL CROWDFUNDING MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
TABLE 324. EUROPE, MIDDLE EAST & AFRICA MEDICAL CROWDFUNDING MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
TABLE 325. EUROPE, MIDDLE EAST & AFRICA MEDICAL CROWDFUNDING MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 326. EUROPE, MIDDLE EAST & AFRICA MEDICAL CROWDFUNDING MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 327. EUROPE, MIDDLE EAST & AFRICA MEDICAL CROWDFUNDING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 328. EUROPE, MIDDLE EAST & AFRICA MEDICAL CROWDFUNDING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 329. EUROPE, MIDDLE EAST & AFRICA MEDICAL CROWDFUNDING MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 330. EUROPE, MIDDLE EAST & AFRICA MEDICAL CROWDFUNDING MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 331. EUROPE, MIDDLE EAST & AFRICA MEDICAL CROWDFUNDING MARKET SIZE, BY PLATFORM TYPE, 2018-2024 (USD MILLION)
TABLE 332. EUROPE, MIDDLE EAST & AFRICA MEDICAL CROWDFUNDING MARKET SIZE, BY PLATFORM TYPE, 2025-2030 (USD MILLION)
TABLE 333. EUROPE, MIDDLE EAST & AFRICA MEDICAL CROWDFUNDING MA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Medical Crowdfunding Market report include:
  • GoFundMe, Inc.
  • JustGiving Limited
  • Fundly, Inc.
  • FundRazr, Inc.
  • GiveButter, Inc.
  • Mightycause, Inc.
  • Plumfund, Inc.
  • Generosity.com, Inc.
  • Watsi, Inc.
  • GiveSendGo, LLC